AAAAAA

   
Results: 1-25 | 26-34 |
Results: 26-34/34

Authors: Balaton, AJ Le Doussal, V Arnould, L Barlier, C Bellocq, JP Ettore, F Fiche, M Jacquemier, J Mac Grogan, G Mathieu, MC Migeon, C Penault-Llorca, F Pignodel, C Roger, P Simony-Lafontaine, J Treilleux, I Verrielle, V Vilain, MO Voigt, JJ Zafrani, B
Citation: Aj. Balaton et al., Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast carcinomas. Update 1999, ANN PATHOL, 19(4), 1999, pp. 336-343

Authors: Penault-Llorca, F Jacquemier, J
Citation: F. Penault-llorca et J. Jacquemier, Factors predicting treatment responsiveness, prognosis, or carcinogenetic status : current aspects of ERBB-2 activation in breast cancer, ANN PATHOL, 19(2), 1999, pp. 103-115

Authors: Viens, P Jacquemier, J Bardou, VJ Bertucci, F Penault-Llorca, F Puig, B Gravis, G Oziel-Taieb, S Resbeut, M Houvenaeghel, G Camerlo, J Birbaum, D Hassoun, J Maraninchi, D
Citation: P. Viens et al., Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy, BREAST CANC, 54(3), 1999, pp. 205-212

Authors: Eisinger, F Nogues, C Guinebretiere, JM Peyrat, JP Bardou, VJ Noguchi, T Vennin, P Sauvin, R Lidereau, R Birnbaum, D Jacquemier, J Sobol, H
Citation: F. Eisinger et al., Novel indications for BRCA1 screening using individual clinical and morphological features, INT J CANC, 84(3), 1999, pp. 263-267

Authors: Jacquemier, J Eisinger, F Nogues, C Sun, ZZ Guinebretiere, JM Peyrat, JP Geneix, J Lidereau, R Birnbaum, D Sobol, H
Citation: J. Jacquemier et al., Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancers, INT J CANC, 83(1), 1999, pp. 45-49

Authors: Eisinger, F Jacquemier, J Nogues, C Birnbaum, D Sobol, H
Citation: F. Eisinger et al., Steroid receptors in hereditary breast carcinomas associated with BRCA1 orBRCA2 mutations or unknown susceptibility genes, CANCER, 85(10), 1999, pp. 2291-2293

Authors: Viens, P Palangie, T Janvier, M Fabbro, M Roche, H Delozier, T Labat, JP Linassier, C Audhuy, B Feuilhade, F Costa, B Delva, R Cure, H Rousseau, F Guillot, A Mousseau, M Ferrero, JM Bardou, VJ Jacquemier, J Pouillart, P
Citation: P. Viens et al., First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial), BR J CANC, 81(3), 1999, pp. 449-456

Authors: Ghnassia, JP Vilain, MO Coindre, JM Bertrand, G Chateau, MC Collin, F Depardieu, C Fiche, M Guillou, L Jacquemier, J Larsimont, D Le Doussal, V Leroux-Broussier, A Mandard, AM Marques, B Ranchere, D Sastre, X Terrier, P Trassard, M
Citation: Jp. Ghnassia et al., Management of adult soft tissue sarcomas: recommendations for pathologistsby the FNCLCC Sarcoma Group., ANN PATHOL, 18(6), 1998, pp. 505-511

Authors: Sobol, H Eisinger, F Sauvan, R Noguchi, T Jacquemier, J Birnbaum, D
Citation: H. Sobol et al., Recent advances in breast cancer genetics: impact in medical management ofBRCA-cancer prone women, ANN ENDOCR, 59(6), 1998, pp. 459-464
Risultati: 1-25 | 26-34 |